V Iu Kulikov

Learn More
The role of platelet-activating factor (PAF, a phospholipid compound) in regulation of cell functions and cell-cell interactions is reviewed. The biological effects of PAF on platelets, neutrophils, basophils, eosinophiles, lymphocytes, and endothelial cells are described. Mechanisms of cell activation by PAF are discussed. Interactions of PAF with other(More)
FOREWORD During the last decade a number of publications have been issued containing information about the past nuclear weapons tests and their radiological consequences for the environment and the public. In Russia, monographs devoted to operation of the Semipalatinsk Test Site, Kazakhstan, and the North Test Site, located on the Novaya Zemlya archipelago(More)
In this study we investigated the effect of risk factors of metabolic syndrome on the content of light hydrocarbons (C2-C3) in exhaled air. We used a gas chromatograph with a short multi-channel column. As a result, sex differences in concentrations of light hydrocarbons presented in exhaled air were found. In addition, such factors as smoking and diabetes(More)
The influence of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine, a platelet activating factor (PAF), and its structural analogs--1-acyl-2-acetyl-sn-glycero-3-phosphocholine and 1-(1'-alkenyl)-glycero-3-phosphocholine--on the histamine release from human leukocytes of healthy and allergic individuals was investigated. It was found that within the(More)
It was shown that the content of the lipid peroxide oxidation products and basic lipid and soluble antioxidant products in capillary and venous blood reflect the tissue trophy provision process in the chronic ecology stress condition. The high reactive oxygen species (ROS) generation in the xanthine-xanthine oxidase system is one of the important mechanisms(More)
Prostaglandin E1 (PGE1) and platelet activation factor (PAF) were found respectively to activate or to inhibit cholesterol esterification in whole plasma but not in lipoprotein-deficient plasma. It is suggested that these effects are mediated by the interaction of PGE1 and PAF with high-density lipoproteins [(1984) FEBS Lett. 173, 291-294]. Possible(More)
The interaction of a plasmalogenic analog of platelet-activating factor (1-O-alk-1;-enyl-2-acetyl-sn-glycero-3-phosphocholine; 1-alkenyl-PAF) with human platelets was studied. 1-Alkenyl-PAF induced an increase in intracellular Ca2+ concentration and inhibition of adenylate cyclase at significantly higher concentrations than PAF. 1-Alkenyl-PAF inhibits(More)